New Zealand biotech firm tackling COVID-19 and M. bovis

18 May 2020

Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis.

Read More

Initial funding opens doors for national vaccine strategy

08 May 2020

New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.

Read More

COVID-19: The massive social and economic experiment

06 May 2020

Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted.

Read More
Industry News
Topics
Industry News

BioScience Managers invests in REX Bionics

Australian life sciences investment firm BioScience Managers has chosen a robotic exercise assist device (REX) as its first investment for the Biomedical Translation Fund.
12 September 2017
Industry News

$20m fund for the future of farming

A National Government will partner with farmers and growers to develop new farming technology and practices that lift productivity and further reduce farming’s environmental footprint, Primary Industries spokesperson Nathan Guy says.
12 September 2017
Industry News

Tru-Test names Simon Mander as new chief executive

Tru-Test Corp has hired Simon Mander to lead the agritech company as it looks to build earnings after a hard round of cost-cutting in response to last year’s dairy downturn.
11 September 2017